Jabez Biosciences is a clinical-stage biotechnology company that is developing small molecule inhibitors for the treatment of both solid and liquid cancers. Our lead drug candidate, JBZ-001, is a small molecule inhibitor of a crucial enzyme involved in the de novo synthesis of pyrimidine nucleotides, DHODH, that displays highly optimized therapeutic qualities.

Contact Us:

2009 Mackenzie Way, Suite 100, Cranberry Township, Pennsylvania 16066

888-645-3947

https://www.jabezbio.com/

10:00AM - 9:00 PM EST

https://www.facebook.com/profile.php?id=61571511998929

https://x.com/Jabezbio

https://www.linkedin.com/company/jabezbiosciences/about/?viewAsMember=t…

https://maps.app.goo.gl/x9qSr5WPfsbd62EK9

https://www.instagram.com/jabezbio/

https://www.tiktok.com/@jabezbio?lang=en

https://youtu.be/9NO-4EPFJaQ?feature=shared

Keywords:

CancerResearch, Oncology, CancerTreatment, Biotech, JabezBioscience, BiotechInvesting, StockInvesting, Investing, Stocks

Payment Accepted

(All types)